Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population.
Michael G. FitzGerald(Broad Institute), Daniel A. Haber(Howard Hughes Medical Institute), James Koh(Unknown), Dianne M. Finkelstein(Harvard University), Edward O’Neill(Massachusetts General Hospital), Sandra Silva-Arrieta(Harvard University), L C Lucchina(Massachusetts General Hospital), Deborah J. MacDonald(Edinburgh Royal Infirmary), Kurt J. Isselbacher(Harvard University), Hilal Ünsal(Massachusetts General Hospital), A J Sober(Massachusetts General Hospital), D. Paul Harkin(Harvard University)
Cited by 201